Analytical method for simultaneous estimation of efonidipine hydrochloride ethanolate and telmisartan by validated RP-HPLC method
Abstract
This research aimed to develop and validate a specific, precise, accurate, robust and cost-effective reversed phase high performance liquid chromatoghraphic method for simultaneous quantification of Efonidipine Hydrochloride Ethanolate and Telmisartan in synthetic mixture. Efonidipine Hydrochloride Ethanolate is a L- and T- type dual calcium channel blocker and Telmisartan is angiotensin receptor blocker given in patient having essential hypertension associated with diabetes and no produced reflex tachycardia. The literature survey disclosed no reported method available for simultaneous eatimation method for this combination. Hence, an attempt was made to develop and validate the reversed phase high performance liquid chromatoghraphic method. In developed RP-HPLC method, analytes sepration were employing Waters C18 Column (150 mm × 4.6 mm, 5 μm). The quantification is carried out using mobile phase Potassium Dihydrogen Orthophosphate: Acetonitrile (30:70 v/v %) containing 1 % orthophosphoric acid were mixed to adjust pH 3. Area were recorded at 254 nm for both analytes and retention time was found to be 7.933 min and 3.187 min for Efonidipine Hydrochloride Ethanolate and Telmisartan at 0.8 ml/min flow rate. The estimation method validated according to the ICH Q2 (R1) guideline. The validated data represent that the develop method was linear over a concentration range of 5-30 μg/ml for Efonidipine Hydrochloride Ethanolate and 10-60 μg/ml Telmisartan.The Accuracy in terms of…
Read the paper
Related studies
- Diagnosis and management of glutaric aciduria type I – revised recommendations
- EZH2 Codon 641 Mutations are Common in BCL2-Rearranged Germinal Center B Cell Lymphomas
- Consensus guidelines for the diagnosis and management of pyridoxine‐dependent epilepsy due to α‐aminoadipic semialdehyde dehydrogenase deficiency
- Systemic Metabolomic Changes in Blood Samples of Lung Cancer Patients Identified by Gas Chromatography Time-of-Flight Mass Spectrometry
- Human OTULIN haploinsufficiency impairs cell-intrinsic immunity to staphylococcal α-toxin
- Discovery of Novel Recurrent Mutations in Childhood Early T-Cell Precursor Acute Lymphoblastic Leukemia by Whole Genome Sequencing - a Report From the St Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.